De Giorgi, Ugo Federico Francesco
 Distribuzione geografica
Continente #
NA - Nord America 135
EU - Europa 110
AS - Asia 50
Totale 295
Nazione #
US - Stati Uniti d'America 133
IT - Italia 33
CN - Cina 30
IE - Irlanda 28
SE - Svezia 12
FR - Francia 10
BE - Belgio 9
GB - Regno Unito 6
VN - Vietnam 4
IR - Iran 3
JP - Giappone 3
DE - Germania 2
IN - India 2
NL - Olanda 2
PH - Filippine 2
PL - Polonia 2
AM - Armenia 1
CA - Canada 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
KR - Corea 1
MK - Macedonia 1
MX - Messico 1
NO - Norvegia 1
RO - Romania 1
RU - Federazione Russa 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 295
Città #
Chandler 40
Dublin 28
Fairfield 12
Nyköping 9
Torino 9
Houston 7
Medford 7
Redwood City 7
Princeton 5
Seattle 5
Shanghai 5
Esneux 4
Paris 4
Turin 4
Beijing 3
Chengdu 3
Sigean 3
Wilmington 3
Ashburn 2
Bellingham 2
Brussels 2
Cambridge 2
Hangzhou 2
Hebei 2
Klaaswaal 2
Nanjing 2
Rome 2
San Diego 2
Woodbridge 2
Akron 1
Ankara 1
Ann Arbor 1
Ashiharacho 1
Bangalore 1
Boston 1
Changsha 1
Cluj-napoca 1
Deposit 1
Duncan 1
El Fuerte 1
Fremont 1
Frosinone 1
Guiyang 1
Harbin 1
Hayward 1
Homer 1
Homps 1
Hyderabad 1
Jacksonville 1
Kagoshima 1
London 1
Macerata 1
Moncalieri 1
Nanchang 1
Nonette 1
Norwalk 1
Oslo 1
Pittsburgh 1
Plainville 1
Prilep 1
Riverton 1
San Jose 1
Seoul 1
Seregno 1
Seriate 1
Suzhou 1
Taipei 1
Taormina 1
Toronto 1
Wigan 1
Wuhan 1
Zhengzhou 1
Totale 223
Nome #
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer 170
Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21) 39
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 29
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 27
The prognostic value of pain in castration-sensitive prostate cancer 21
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort 9
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study 6
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society 3
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 2
Totale 306
Categoria #
all - tutte 673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 673


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0000 20 01 1014
2020/202174 1354 59 32 62097
2021/2022100 411211 65 35 1431818
2022/2023123 8729 1732 1223 13000
Totale 306